Plasma cell mastitis (PCM)

Plasma cell mastitis (PCM) is a rare, chronic inflammatory condition of the breast, primarily affecting middle-aged and older women. It is characterized by the infiltration of plasma cells into the breast tissue, leading to various symptoms and potential complications. This condition is often confused with other breast diseases, making accurate diagnosis crucial for effective management.

Etiology and Pathophysiology

The exact cause of plasma cell mastitis remains unclear, but it is believed to be associated with duct ectasia, a condition where the milk ducts beneath the nipple become dilated and filled with fluid. This can lead to inflammation and the subsequent infiltration of plasma cells. Other potential contributing factors include hormonal changes, autoimmune responses, and bacterial infections, although these are less commonly implicated.

In PCM, the immune system's response to the ductal changes results in the accumulation of plasma cells, a type of white blood cell, in the breast tissue. This infiltration can cause the formation of granulomas and fibrosis, leading to the characteristic symptoms of the disease.

Clinical Presentation

Patients with plasma cell mastitis may present with a variety of symptoms, which can sometimes mimic those of breast cancer. Common symptoms include:

• Breast pain or tenderness
• Nipple discharge, which may be bloody or purulent
• Nipple retraction or inversion
• Palpable lumps or masses in the breast
• Skin changes, such as redness or thickening

These symptoms can vary in severity and may be unilateral or bilateral. The chronic nature of PCM means that symptoms can persist for extended periods, often leading to significant discomfort and anxiety for the patient.

Diagnosis

Diagnosing plasma cell mastitis can be challenging due to its similarity to other breast conditions, particularly breast cancer. A thorough clinical evaluation is essential, often involving:

1. Physical Examination: A detailed examination of the breast to assess the presence of lumps, skin changes, and nipple discharge.
2. Imaging Studies: Mammography and ultrasound are commonly used to evaluate the breast tissue. These imaging modalities can help differentiate PCM from malignant conditions, although they may not provide a definitive diagnosis.
3. Biopsy: A core needle biopsy or excisional biopsy is often necessary to confirm the diagnosis. Histological examination will reveal the presence of plasma cells and other inflammatory changes characteristic of PCM.

Treatment and Management

The management of plasma cell mastitis focuses on alleviating symptoms and preventing complications. Treatment options may include:

• Antibiotics: If a bacterial infection is suspected, antibiotics may be prescribed to address any underlying infection.
• Anti-inflammatory Medications: Nonsteroidal anti-inflammatory drugs (NSAIDs) can help reduce pain and inflammation.
• Surgical Intervention: In cases where there is significant ductal involvement or abscess formation, surgical intervention may be necessary. This can include duct excision or drainage of abscesses.
• Hormonal Therapy: In some cases, hormonal therapy may be considered, particularly if there is a suspected hormonal component to the condition.

It is important for patients to have regular follow-up appointments to monitor the condition and adjust treatment as necessary.

Prognosis

The prognosis for plasma cell mastitis is generally favorable, although the condition can be persistent and recurrent. With appropriate management, most patients experience significant symptom relief. However, due to the chronic nature of PCM, ongoing monitoring and treatment adjustments may be required.

Sinomenine hydrochloride inhibits the progression of plasma cell mastitis.